Therapy Areas: Inflammatory Diseases
17 November 2017 - - US-based biotechnology company Evelo Biosciences is collaborating with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and neuroin...
16 November 2017 - - The global ophthalmic drugs market was valued at USD 29,613m in 2016, and is projected to reach USD 42,663m by 2023, growing at a CAGR of 5.3% f...
16 November 2017 - - US-based clinical trial stage biopharmaceutical company Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) has initiated an Open Label Extension (OLE) study of Ampion in patients w...
16 November 2017 - Healthcare company Swedish Orphan Biovitrum AB (publ) (Sobi) stated on Wednesday that it has randomised the first patient to evaluate efficacy and safety of anakinra in the treatmen...
15 November 2017 - AstraZeneca (NYSE:AZN) and its biologics research and development arm MedImmune on Tuesday jointly announced the receipt of approval from the US Food and Drug Administration (FDA) f...
14 November 2017 - - Thousand Oaks, California-based human therapeutics developer Amgen (NASDAQ: AMGN) has released five new subgroup analyses from the Repatha (evolocumab) cardiovascular outcome...